Free shipping on all orders over $ 500

BCTC

Cat. No. M6494

All AbMole products are for research use only, cannot be used for human consumption.

BCTC Structure
Size Price Availability Quantity
5mg USD 60 In stock
10mg USD 80 In stock
25mg USD 160 In stock
50mg USD 270 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

BCTC is a orally effective vanilloid receptor 1 (TRPV1 receptor) antagonist. BCTC is also a potent and specific inhibitor of transient receptor potential cation channel subfamily M member 8 (TRPM8) in prostate cancer (PCa) DU145 cells. BCTC inhibits acid- and capsaicin-induced activation of rat TRPV1 receptors (IC50 values are 6.0 and 35 nM respectively). BCTC displays analgesic properties in rat models of inflammatory and neuropathic pain.

Product Citations
Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models Jugular-cannulated male Sprague-Dawley rats (200-300 g)
Formulation using 25% hydroxypropyl-β-cyclodextrin as vehicle
Dosages 3, 10, and 40 mg/kg p.o. or 3 mg/kg i.v.
Administration p.o. or i.v.
Chemical Information
Molecular Weight 372.89
Formula C20H25ClN4O
CAS Number 393514-24-4
Solubility (25°C) DMSO ≥ 38 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Tao Liu, et al. Oncol Lett. Anti-tumor activity of the TRPM8 inhibitor BCTC in prostate cancer DU145 cells

[2] Kenneth J Valenzano, et al. J Pharmacol Exp Ther. N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties

[3] Houlihan, et al. J Neurochem. Activity of cytisine and its brominated isoteres on recombinant human α7, α4β2 and α4β4 nicotinic acetylcholine receptors.

Related TRP Channel Products
SB-705498

SB-705498 is a potent, selective and orally bioavailable transient receptor potential vanilloid 1 (TRPV1) receptor antagonist with a pIC50 of 7.1.

HC-030031

HC-030031 is a selective TRPA1 blocker, antagonizing TRPA1-mediated calcium influx induced by AITC and formalin (IC50 = 6.2 and 5.3 μM, respectively).

AMG-517

AMG 517 is a potent and selective TRPV1 antagonist, antagonizes capsaicin, proton, and heat activation of TRPV1 with IC50 of 0.76 nM, 0.62 nM and 1.3 nM.

Icilin

Icilin is a synthetic super-agonist of the transient receptor potential M8 (TRPM8) ion channel.

Phenazopyridine hydrochloride

Phenazopyridine HCl is a competitive SARM1 inhibitor as well as a TRPM8 antagonist with an IC50 for SARM1 inhibition of 145 μM. It has local anesthetic/analgesic activity and can be used in studies related to traumatic brain injury, peripheral neuropathy, and neurodegenerative diseases.

  Catalog
Abmole Inhibitor Catalog




Keywords: BCTC supplier, TRP Channel, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.